4//SEC Filing
HALAS GUS D 4
Accession 0001213900-22-017500
CIK 0001448431other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:47 PM ET
Size
5.6 KB
Accession
0001213900-22-017500
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
HALAS GUS D
Director
Transactions
- Award
Restricted Stock Units
2022-03-30+657→ 657 total→ Common Stock (657 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
- [F2]The restricted stock units vest on March 30, 2023.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001230322
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:47 PM ET
- Size
- 5.6 KB